Evidence map›Paper›PMID 31690631›Full record

ArticleThe Journal of biological chemistry2019

Doxorubicin causes lesions in the electron transport system of skeletal muscle mitochondria that are associated with a loss of contractile function.

Michael D Tarpey, Adam J Amorese, Nicholas P Balestrieri, Kelsey H Fisher-Wellman, Espen E Spangenburg

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. FASEB bioAdvances · 2023
    Article
  12. Review
  13. Observational
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael D TarpeyDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834.ORCID 0000-0002-0466-6462
Adam J AmoreseDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834.ORCID 0000-0002-9661-0203
Nicholas P BalestrieriDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834.
Kelsey H Fisher-WellmanDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834.
Espen E SpangenburgDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834 spangenburge14@ecu.edu.
East Carolina University · US

Funding

Risk of Incident Knee OA & Clinical Outcomes Based on Imaging BiomarkersR01AR066601 · NIAMS · UNIVERSITY OF ARIZONA · PI GUERMAZI, ALI, KWOH, C KENT · 2014 to 2018
$6.2M
BRCA1 is necessary for optimal skeletal muscle functionR01AR066660 · NIAMS · EAST CAROLINA UNIVERSITY · PI SPANGENBURG, ESPEN E · 2015 to 2019
$1.6M
NIAMS NIH HHS R01 AR066601NIAMS NIH HHS R01 AR066660
6 · The paper itself

Abstract

Doxorubicin is an anthracycline-based chemotherapeutic that causes myotoxicity with symptoms persisting beyond treatment. Patients experience muscle pain, weakness, fatigue, and atrophy, but the underlying mechanisms are poorly understood. Studies investigating doxorubicin-induced myotoxicity have reported disrupted mitochondrial function. Mitochondria are responsible for regulating both cellular energy status and Ca

Indexed as

Adenosine TriphosphateAnimalsAnthracyclinesCalciumCitrate (si)-SynthaseDoxorubicinElectron TransportIronKineticsMaleMiceMice, Inbred C57BLMitochondria, MuscleMuscle ContractionMuscle FatigueMuscle Fibers, SkeletalAdenosine TriphosphateAnthracyclinesCalciumCitrate (si)-SynthaseDoxorubicinIronanthracycline drugbioenergeticsdoxorubicinelectron transport system (ETS)mitochondrial metabolismmitochondriopathymuscle physiologymuscle wastingmyotoxicityskeletal muscle

Identifiers

PMID31690631
PMCPMC6926446
OpenAlexW2983368916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.